Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 524494 | NSE: IPCALAB

1514.90
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1499.10
  •  1524.45
  •  1460.00
  •  1491.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  622678
  •  9338.51
  •  1755.90
  •  1052.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 36,674.21
  • 50.28
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 37,533.62
  • 0.28%
  • 5.26

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.72%
  • 0.45%
  • 6.88%
  • FII
  • DII
  • Others
  • 11.06%
  • 35.14%
  • 1.75%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.32
  • 10.65
  • 9.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.41
  • 7.26
  • 0.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.89
  • -2.05
  • -15.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.03
  • 32.70
  • 46.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.44
  • 4.99
  • 4.49

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.94
  • 20.52
  • 21.53

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
21.57
34.45
45.15
56
P/E Ratio
70.86
44.37
33.85
27.3
Revenue
7622
8832
9972
11324
EBITDA
1321
1669
2050
2569
Net Income
547
879
1153
1519
ROA
5.6
7.9
9.3
10.6
P/Bk Ratio
6.12
5.34
4.63
3.99
ROE
31.31
32.31
30.67
30.31
FCFF
832.35
761.93
786.86
1001.57
FCFF Yield
2.21
2.02
2.09
2.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
2,245.37
2,052.85
9.38%
2,354.90
2,033.95
15.78%
2,092.63
1,585.21
32.01%
2,033.01
1,511.63
34.49%
Expenses
1,782.29
1,721.97
3.50%
1,913.42
1,673.39
14.34%
1,699.91
1,277.39
33.08%
1,711.11
1,330.59
28.60%
EBITDA
463.08
330.88
39.95%
441.48
360.56
22.44%
392.72
307.82
27.58%
321.90
181.04
77.81%
EBIDTM
20.62%
16.12%
18.75%
17.73%
18.77%
19.42%
15.83%
11.98%
Other Income
20.11
22.45
-10.42%
26.26
38.55
-31.88%
20.61
44.85
-54.05%
18.92
36.39
-48.01%
Interest
16.81
33.40
-49.67%
22.56
44.12
-48.87%
24.05
31.38
-23.36%
29.37
18.45
59.19%
Depreciation
98.46
99.50
-1.05%
100.35
90.34
11.08%
98.89
69.27
42.76%
98.13
69.54
41.11%
PBT
367.92
288.89
27.36%
344.83
225.36
53.01%
290.39
251.82
15.32%
76.60
129.44
-40.82%
Tax
90.59
66.24
36.76%
99.39
87.92
13.05%
91.41
85.61
6.77%
73.69
48.37
52.35%
PAT
277.33
222.65
24.56%
245.44
137.44
78.58%
198.98
166.21
19.72%
2.91
81.07
-96.41%
PATM
12.35%
10.85%
10.42%
6.76%
9.51%
10.48%
0.14%
5.36%
EPS
9.78
7.09
37.94%
9.05
5.72
58.22%
7.58
6.42
18.07%
2.35
3.02
-22.19%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
8,725.91
7,662.43
6,204.26
5,796.74
5,394.94
4,619.03
3,745.69
3,257.76
3,156.19
2,867.11
3,144.40
Net Sales Growth
21.47%
23.50%
7.03%
7.45%
16.80%
23.32%
14.98%
3.22%
10.08%
-8.82%
 
Cost Of Goods Sold
2,756.15
2,251.73
2,079.50
1,790.78
1,547.98
1,455.41
1,090.34
978.34
939.40
903.04
968.00
Gross Profit
5,969.76
5,410.70
4,124.76
4,005.96
3,846.96
3,163.62
2,655.35
2,279.42
2,216.79
1,964.07
2,176.40
GP Margin
68.41%
70.61%
66.48%
69.11%
71.31%
68.49%
70.89%
69.97%
70.24%
68.50%
69.22%
Total Expenditure
7,106.73
6,398.38
5,300.99
4,539.12
3,913.71
3,728.56
3,067.42
2,815.78
2,740.77
2,593.42
2,630.33
Power & Fuel Cost
-
333.97
283.74
242.12
207.10
201.22
176.50
161.92
151.00
141.67
135.94
% Of Sales
-
4.36%
4.57%
4.18%
3.84%
4.36%
4.71%
4.97%
4.78%
4.94%
4.32%
Employee Cost
-
1,708.43
1,287.64
1,177.39
1,013.57
921.23
787.40
735.88
695.98
625.58
566.70
% Of Sales
-
22.30%
20.75%
20.31%
18.79%
19.94%
21.02%
22.59%
22.05%
21.82%
18.02%
Manufacturing Exp.
-
892.99
655.66
610.03
524.21
471.80
374.26
366.92
404.52
387.75
439.11
% Of Sales
-
11.65%
10.57%
10.52%
9.72%
10.21%
9.99%
11.26%
12.82%
13.52%
13.96%
General & Admin Exp.
-
345.05
296.10
261.34
242.22
249.90
271.85
268.52
246.68
245.42
246.73
% Of Sales
-
4.50%
4.77%
4.51%
4.49%
5.41%
7.26%
8.24%
7.82%
8.56%
7.85%
Selling & Distn. Exp.
-
745.87
595.47
402.81
324.86
359.15
317.84
277.62
280.74
223.67
245.00
% Of Sales
-
9.73%
9.60%
6.95%
6.02%
7.78%
8.49%
8.52%
8.89%
7.80%
7.79%
Miscellaneous Exp.
-
120.34
102.88
54.65
53.77
69.85
49.23
26.58
22.45
66.29
245.00
% Of Sales
-
1.57%
1.66%
0.94%
1.00%
1.51%
1.31%
0.82%
0.71%
2.31%
0.92%
EBITDA
1,619.18
1,264.05
903.27
1,257.62
1,481.23
890.47
678.27
441.98
415.42
273.69
514.07
EBITDA Margin
18.56%
16.50%
14.56%
21.70%
27.46%
19.28%
18.11%
13.57%
13.16%
9.55%
16.35%
Other Income
85.90
184.36
151.77
121.72
129.19
86.50
74.66
58.08
54.76
40.77
58.69
Interest
92.79
140.75
48.19
11.20
12.27
19.77
22.24
27.57
26.91
34.56
32.13
Depreciation
395.83
357.24
261.56
232.42
209.17
210.50
182.42
177.73
172.95
163.26
179.55
PBT
1,079.74
950.42
745.29
1,135.72
1,388.98
746.70
548.27
294.76
270.32
116.64
361.08
Tax
355.08
313.46
253.36
224.77
240.14
135.33
104.24
51.11
67.52
20.44
101.93
Tax Rate
32.89%
37.20%
33.99%
19.79%
17.29%
18.12%
19.01%
17.34%
24.98%
17.52%
28.23%
PAT
724.66
553.64
484.26
905.24
1,147.71
614.13
447.39
243.65
202.80
96.20
259.15
PAT before Minority Interest
731.53
529.21
491.93
910.95
1,148.84
611.37
444.03
243.65
202.80
96.20
259.15
Minority Interest
6.87
24.43
-7.67
-5.71
-1.13
2.76
3.36
0.00
0.00
0.00
0.00
PAT Margin
8.30%
7.23%
7.81%
15.62%
21.27%
13.30%
11.94%
7.48%
6.43%
3.36%
8.24%
PAT Growth
19.31%
14.33%
-46.50%
-21.13%
86.88%
37.27%
83.62%
20.14%
110.81%
-62.88%
 
EPS
28.56
21.82
19.09
35.68
45.24
24.21
17.63
9.60
7.99
3.79
10.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,332.19
5,842.02
5,464.84
4,701.65
3,627.48
3,122.39
2,688.57
2,455.26
2,259.19
2,208.43
Share Capital
25.37
25.37
25.37
25.37
25.27
25.27
25.24
25.24
25.24
25.24
Total Reserves
6,305.21
5,816.65
5,439.47
4,676.28
3,590.27
3,097.12
2,663.01
2,430.02
2,233.95
2,183.19
Non-Current Liabilities
1,014.41
901.72
613.87
189.69
290.29
313.40
419.42
548.32
662.57
699.57
Secured Loans
580.41
651.78
395.18
9.13
88.80
133.94
234.01
347.22
433.63
447.65
Unsecured Loans
0.00
0.00
0.00
0.00
14.17
6.91
0.00
4.52
50.64
55.56
Long Term Provisions
86.84
46.99
42.73
38.56
32.23
25.28
25.88
24.55
20.22
18.03
Current Liabilities
2,355.64
1,805.82
1,465.88
1,160.54
1,326.42
1,097.50
1,007.57
955.93
969.95
904.36
Trade Payables
776.08
525.06
557.70
664.86
609.85
524.32
423.47
396.54
421.11
306.59
Other Current Liabilities
732.62
488.15
420.52
204.49
304.57
274.74
266.75
316.41
297.50
236.44
Short Term Borrowings
559.24
661.82
367.81
176.61
310.95
209.69
239.04
177.30
184.85
325.35
Short Term Provisions
287.70
130.79
119.85
114.58
101.05
88.75
78.31
65.68
66.49
35.98
Total Liabilities
11,097.05
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
Net Block
4,553.53
2,751.38
2,402.19
2,072.43
2,058.73
1,940.38
1,952.96
1,983.27
2,014.18
1,800.43
Gross Block
7,020.79
4,353.42
3,749.46
3,201.39
2,985.73
2,632.86
2,464.33
2,318.22
2,176.95
2,546.33
Accumulated Depreciation
2,467.26
1,602.04
1,331.43
1,128.96
927.00
692.48
511.37
334.95
162.77
745.90
Non Current Assets
5,558.15
3,433.59
3,164.34
2,629.45
2,402.11
2,171.08
2,170.08
2,217.69
2,269.79
2,198.38
Capital Work in Progress
342.89
140.43
306.43
234.82
133.28
66.33
73.00
94.64
128.74
267.22
Non Current Investment
303.61
302.66
269.88
111.43
71.31
30.05
17.52
22.24
25.82
16.19
Long Term Loans & Adv.
315.59
229.61
169.63
184.42
124.68
128.36
115.83
103.58
78.44
103.47
Other Non Current Assets
42.53
9.51
16.21
26.35
14.11
5.96
10.77
13.96
22.61
11.07
Current Assets
5,535.55
5,189.27
4,457.17
3,436.96
2,855.71
2,377.75
1,945.48
1,741.82
1,621.92
1,613.98
Current Investments
558.40
323.32
719.31
393.83
238.25
90.38
69.35
113.57
0.00
0.00
Inventories
2,471.31
1,743.37
1,857.97
1,594.81
1,323.12
1,072.50
880.59
882.22
837.42
926.56
Sundry Debtors
1,686.51
989.02
910.78
811.75
895.20
681.51
602.27
500.16
445.87
353.00
Cash & Bank
296.84
1,853.24
640.66
365.07
180.92
282.30
150.57
35.85
175.54
124.79
Other Current Assets
522.49
124.70
126.65
234.70
218.22
251.06
242.70
210.02
163.09
209.63
Short Term Loans & Adv.
197.48
155.62
201.80
36.80
22.30
29.85
14.44
15.56
17.31
36.19
Net Current Assets
3,179.91
3,383.45
2,991.29
2,276.42
1,529.29
1,280.25
937.91
785.89
651.97
709.62
Total Assets
11,093.70
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
944.65
805.81
856.07
1,090.13
570.35
501.03
341.13
281.91
708.65
455.29
PBT
842.67
745.29
1,135.72
1,388.98
738.89
546.46
290.53
262.06
116.64
361.08
Adjustment
489.87
235.18
195.11
183.07
247.37
187.36
192.51
174.86
211.11
187.91
Changes in Working Capital
-91.59
48.99
-272.72
-236.33
-263.69
-121.97
-84.44
-103.73
410.30
-18.68
Cash after chg. in Working capital
1,240.95
1,029.46
1,058.11
1,335.72
722.57
611.85
398.60
333.19
738.05
530.31
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-296.30
-223.65
-202.04
-245.59
-152.22
-110.82
-57.47
-51.28
-29.40
-75.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,291.79
-725.00
-855.05
-520.69
-509.65
-165.06
-135.40
-148.82
-218.33
-676.40
Net Fixed Assets
-337.88
-335.30
-597.37
-307.20
-284.34
-46.98
-60.09
-105.61
466.60
-716.66
Net Investments
-1,597.43
281.97
-470.86
-219.12
-326.48
-106.61
-4.05
-114.15
-15.57
-52.96
Others
643.52
-671.67
213.18
5.63
101.17
-11.47
-71.26
70.94
-669.36
93.22
Cash from Financing Activity
-552.55
507.24
426.78
-305.82
-136.54
-183.20
-130.41
-159.13
-461.51
250.54
Net Cash Inflow / Outflow
-899.69
588.05
427.80
263.62
-75.84
152.77
75.32
-26.04
28.81
29.43
Opening Cash & Equivalents
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
140.06
74.25
Closing Cash & Equivalent
755.79
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
103.68

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
249.53
230.27
215.41
185.32
286.15
247.12
213.02
194.55
179.02
174.99
ROA
5.37%
6.06%
13.31%
20.29%
12.47%
10.25%
6.03%
5.17%
2.50%
7.38%
ROE
8.70%
8.70%
17.92%
27.63%
18.15%
15.28%
9.47%
8.60%
4.31%
12.43%
ROCE
13.10%
11.71%
20.46%
30.92%
19.92%
16.53%
9.94%
9.44%
4.82%
13.78%
Fixed Asset Turnover
1.35
1.54
1.68
1.75
1.65
1.48
1.37
1.43
1.23
1.42
Receivable days
63.37
55.52
53.92
57.48
61.90
62.09
61.27
53.75
50.16
46.12
Inventory Days
99.83
105.25
108.09
98.25
94.05
94.47
97.98
97.70
110.76
101.93
Payable days
100.50
86.04
111.16
136.39
49.85
51.13
50.35
52.23
52.92
39.11
Cash Conversion Cycle
62.70
74.74
50.86
19.34
106.10
105.43
108.90
99.22
108.00
108.95
Total Debt/Equity
0.22
0.25
0.14
0.05
0.13
0.15
0.23
0.29
0.38
0.42
Interest Cover
6.99
16.47
102.40
114.20
38.77
25.65
11.69
11.05
4.38
12.24

News Update:


  • Ipca Laboratories secures approval for voluntary closure of Mexico-based subsidiary
    5th Dec 2024, 12:21 PM

    Voluntary closure of this wholly owned subsidiary will not have any impact on Company’s business or financials

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.